Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects With Rheumatoid Arthritis

NCT03025308 is registered in ClinicalTrials.gov with Alfasigma S.p.A. as lead sponsor.

NCT NCT03025308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03025308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects With Rheumatoid Arthritis
Lead sponsor
Alfasigma S.p.A.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2017
Completion date
May 16, 2025
Enrollment
2,731 (actual)
Sites
345

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis